Non-operative Treatment in Sweden of Proximal Humeral Fractures (NOSWEPH)

February 17, 2021 updated by: Lars Adolfsson

Non-operative Treatment in Sweden of Proximal Humeral Fratures, a Randomised Multicenter Trial.

Proximal humeral fractures are common especially in the elderly population. The majority of these fractures are minimally displaced and may be treated non-operatively. There is however a controversy about which fractures that need surgery and randomised trials have not been able to show a clinically important advantage in patient reported outcome measures for those operated. The trend is therefore that also displaced and comminute fractures are treated non-operatively. There is however very little scientific support for how the non-operative treatment should be designed and performed. Therefore this prospective multicenter study is aiming at investigating the benefit of a four week immobilisation orthosis as compared to early range of motion exercises for those patients not assigned for surgery one week after the trauma.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

400

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • A proximal humeral fracture verified on radiology no older than 7-10 days.

Exclusion Criteria:

  • Surgically treated proximal humeral fracture
  • Fracture only involving the greater tuberosity
  • Previous surgery in the fractured shoulder
  • Ongoing malignancy in the fractured shoulder
  • Neurologic disease
  • Radiating pain from the neck in the affected arm
  • Associated vascular or nerve injuries
  • Dementia
  • Alcohol abuse
  • Unwilling to participate in the trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Orthosis group
An orthosis with the broken arm in neutral position fixed for four weeks. After these four weeks the patient is instructed to start rehabilitation.
Application of orthosis and start of rehabilitation after four weeks.
Active Comparator: Early rehabilitation group
The patient is instructed to start early rehabilitation about one week after the trauma.
Application of orthosis and start of rehabilitation after four weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Union of fracture
Time Frame: Followed 12 months
recording of fracture union on radiological images
Followed 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxford shoulder score
Time Frame: 12 months
Shoulder specific patient reported outcome measure, PROM, with a maximum score of 48 points
12 months
Numerical pain reporting scale
Time Frame: 12 months
Patient reported outcome measure of pain at rest, at night and during activity in scales with 10 steps grading subjective assessment of pain
12 months
Quick DASH
Time Frame: 12 months
Patient reported outcome measure of shoulder function in a 11-item PROM
12 months
Global assessment of improvement
Time Frame: 12 months
Patient rated assessment of global improvement in a numeric scale with 7 steps
12 months
Shoulder range of motion
Time Frame: 12 months
The elevation, abduction, internal and external rotation of the injured shoulder
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Lars E Adolfsson, Professor, Linkoeping University
  • Principal Investigator: Hanna C Björnsson Hallgren, MD, PhD, Linkoeping University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 25, 2019

Primary Completion (Anticipated)

February 25, 2022

Study Completion (Anticipated)

February 25, 2024

Study Registration Dates

First Submitted

November 5, 2018

First Submitted That Met QC Criteria

December 23, 2018

First Posted (Actual)

December 26, 2018

Study Record Updates

Last Update Posted (Actual)

February 21, 2021

Last Update Submitted That Met QC Criteria

February 17, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Proximal Humeral Fracture

Clinical Trials on Ultrasling ER III orthosis

3
Subscribe